PMC Weekly Review - February 6, 2015
A Macro View – January Monthly Recap
Domestic equity markets got off to a rough start in 2015, in a similar scenario to 2014. Stocks tumbled right out of the gate as concerns about economic growth in international regions began to creep into U.S. markets. The S&P 500 index shed more than 3% in the first two weeks of trading before stabilizing somewhat. Economic data continued to trend higher, with real Gross Domestic Product (GDP) and employment remaining key drivers of market activity. The first estimate of fourth quarter real GDP came in at +2.6%, slightly below the forecast of 3.0%. Earnings season also began favorably, with about 77% of S&P 500 companies beating analysts’ earnings estimates. Crude oil staged a recovery at the end of the month, generating its largest two-week rally since 1998.
With this environment as a backdrop, stocks posted generally negative results in January. The S&P 500 declined -3.0% for the month, it’s second straight negative monthly return. The Dow Jones Industrials shed -3.6% gain for the month. The tech-heavy Nasdaq Composite Index declined -2.1% in January. The Russell 2000 Index of small cap stocks was weak on a relative basis during the month, being outperformed by the Russell 1000 Index of large cap stocks, with returns of -3.2% and -2.8%, respectively. Growth stocks outperformed value stocks during the month. In terms of sector performance, the top performers in the month were utilities, health care and consumer staples with returns of +2.4%, +1.2% and -1.1%, respectively. Financials and energy were the poorest performers, with returns of -6.9% and -4.8%, respectively.
International equity markets fared, on balance, somewhat better than domestic U.S. indices in January. Markets responded to the announcement by the European Central Bank (ECB) that it would commence a U.S.-style asset purchase program amounting to about $1.3 trillion. The program was initiated to try to invigorate the tepid eurozone economy. The MSCI World ex-U.S. Index declined -0.3% for the month. Emerging markets posted slight gains in January, in part due to a rebound in oil prices in the latter half of the month. The MSCI Emerging Markets Index advanced +0.6% for the month, and the MSCI EAFE Index, which measures developed markets performance, was up +0.5%. Regionally, Asia was the best performer on a relative basis, advancing +2.4%. Latin America and Eastern Europe were among the poorest performers, with results of -6.2% and -2.1%, respectively.
Fixed-income markets fared well in January, as economic growth concerns caused investors to seek the safe haven of U.S. fixed income. Against this backdrop, the 10-year U.S. Treasury yield ended the month at 1.67%, down fifty basis points from the 2.17% level of December 31st. Broad-based fixed-income indices were higher in January, with the Barclays U.S. Aggregate Bond Index gaining +2.1% for the month. Once again, global fixed-income markets performed relatively poorly, with the Barclays Global Aggregate ex-U.S. Index declining -1.8% for the month. Intermediate-term corporate bonds jumped, as the Barclays U.S. Corporate 5-10 Year Index shot up 3.0%. The Barclays U.S. Corporate High Yield Index ended the month with a gain of +0.7%. Municipals continue to generate positive performance, returning +1.8% for the month.
The information, analysis, and opinions expressed herein are for general and educational purposes only. Nothing contained in this weekly review is intended to constitute legal, tax, accounting, securities, or investment advice, nor an opinion regarding the appropriateness of any investment, nor a solicitation of any type. All investments carry a certain risk, and there is no assurance that an investment will provide positive performance over any period of time. An investor may experience loss of principal. Investment decisions should always be made based on the investor’s specific financial needs and objectives, goals, time horizon, and risk tolerance. The asset classes and/or investment strategies described may not be suitable for all investors and investors should consult with an investment advisor to determine the appropriate investment strategy. Past performance is not indicative of future results.
Information obtained from third party sources are believed to be reliable but not guaranteed. Envestnet|PMC™ makes no representation regarding the accuracy or completeness of information provided herein. All opinions and views constitute our judgments as of the date of writing and are subject to change at any time without notice.
Investments in smaller companies carry greater risk than is customarily associated with larger companies for various reasons such as volatility of earnings and prospects, higher failure rates, and limited markets, product lines or financial resources. Investing overseas involves special risks, including the volatility of currency exchange rates and, in some cases, limited geographic focus, political and economic instability, and relatively illiquid markets. Income (bond) securities are subject to interest rate risk, which is the risk that debt securities in a portfolio will decline in value because of increases in market interest rates. Exchange Traded Funds (ETFs) are subject to risks similar to those of stocks, such as market risk. Investing in ETFs may bear indirect fees and expenses charged by ETFs in addition to its direct fees and expenses, as well as indirectly bearing the principal risks of those ETFs. ETFs may trade at a discount to their net asset value and are subject to the market fluctuations of their underlying investments. Investing in commodities can be volatile and can suffer from periods of prolonged decline in value and may not be suitable for all investors. Index Performance is presented for illustrative purposes only and does not represent the performance of any specific investment product or portfolio. An investment cannot be made directly into an index.
Alternative Investments may have complex terms and features that are not easily understood and are not suitable for all investors. You should conduct your own due diligence to ensure you understand the features of the product before investing. Alternative investment strategies may employ a variety of hedging techniques and non-traditional instruments such as inverse and leveraged products. Certain hedging techniques include matched combinations that neutralize or offset individual risks such as merger arbitrage, long/short equity, convertible bond arbitrage and fixed-income arbitrage. Leveraged products are those that employ financial derivatives and debt to try to achieve a multiple (for example two or three times) of the return or inverse return of a stated index or benchmark over the course of a single day. Inverse products utilize short selling, derivatives trading, and other leveraged investment techniques, such as futures trading to achieve their objectives, mainly to track the inverse of their benchmarks. As with all investments, there is no assurance that any investment strategies will achieve their objectives or protect against losses.
Neither Envestnet, Envestnet|PMC™ nor its representatives render tax, accounting or legal advice. Any tax statements contained herein are not intended or written to be used, and cannot be used, for the purpose of avoiding U.S. federal, state, or local tax penalties. Taxpayers should always seek advice based on their own particular circumstances from an independent tax advisor.
© 2015 Envestnet. All rights reserved.